invasive fungal diseases
Conditions
Interventions
Group 1: One-armed observational study. Only laboratory, clinical and imaging parameters from routine clinical practice are collected retrospectively. There are no interventions.
Sponsors
Universitätsklinikum Heidelberg
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Since this is a purely retrospective data analysis, there is no recruitment of patients; rather, patient records are screened to identify suitable records for analysis. The data sets are drawn from the files of patients who suffered from invasive candidiasis [candidemia, intra-abdominal candidiasis (IAC)], invasive aspergillosis (IA), invasive pulmonary aspergillosis (IPA) or any other invasive infection between January 2006 and December 2016 with rare fungal species suffered. In addition, patients should be included who only have a positive galactomannan test (Aspergillus-Ag positive) or a culture of Aspergillus spp. and for whom aspiration (inhalation of food components, e.g. through vomiting) was suspected. With regard to microbiological data: Only information on microbiological data from existing patient files is collected. In the absence of information, no additional samples will be obtained for the study. There is no patient contact.
Exclusion criteria
Exclusion criteria: no specific exclusion criteria
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Prevalance of invasive fungal diseases in ICU patients | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of primary-, secondary- or salvage therapies | — |
Countries
Germany
Contacts
Public ContactSimon Dubler
Universitätsklinikum Heidelberg
Outcome results
None listed